Startseite UR

Publikationen von Loquai, Carmen

Eine Stufe nach oben
Exportieren als
[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Gruppieren nach: Datum | Dokumentenart | Keine Gruppierung
Gehe zu: 2022 | 2021 | 2020 | 2019 | 2017
Anzahl der Einträge: 17.

2022

Livingstone, Elisabeth, Zimmer, Lisa, Hassel, Jessica C, Fluck, Michael, Eigentler, Thomas K , Loquai, Carmen, Haferkamp, Sebastian, Gutzmer, Ralf, Meier, Friedegund , Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian , Kiecker, Felix, Dippel, Edgar, Roesch, Alexander, Ziemer, Mirjana, Conrad, Beate, Körner, Silvia, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C, Schadendorf, Dirk, Livingstone, Elisabeth, Zimmer, Lisa, Hassel, Jessica C, Fluck, Michael, Eigentler, Thomas K, Loquai, Carmen, Haferkamp, Sebastian, Gutzmer, Ralf, Meier, Friedegund, Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian, Kiecker, Felix, Dippel, Edgar, Roesch, Alexander, Ziemer, Mirjana, Conrad, Beate, Körner, Silvia, Simon, Jan-Christoph, Herbst, Rudolf A, Berking, Carola, Utikal, Jochen, Sell, Sabine, Martens, Uwe M, Terheyden, Patrick, Stadler, Rudolf, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C und Schadendorf, Dirk (2022) Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial. The Lancet 400 (10358), S. 1117-1129. Volltext nicht vorhanden.

Spassova, Ivelina , Ugurel, Selma , Kubat, Linda, Zimmer, Lisa , Terheyden, Patrick, Mohr, Annalena, Björn Andtback, Hannah, Villabona, Lisa, Leiter, Ulrike, Eigentler, Thomas , Loquai, Carmen, Hassel, Jessica C, Gambichler, Thilo, Haferkamp, Sebastian, Mohr, Peter, Pfoehler, Claudia, Heinzerling, Lucie, Gutzmer, Ralf, Utikal, Jochen S, Horny, Kai , Schildhaus, Hans-Ulrich, Habermann, Daniel , Hoffmann, Daniel , Schadendorf, Dirk und Becker, Jürgen Christian (2022) Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma. Journal for ImmunoTherapy of Cancer 10 (1), e003198. Volltext nicht vorhanden.

Koch, Elias A. T., Petzold, Anne, Wessely, Anja , Dippel, Edgar, Gesierich, Anja, Gutzmer, Ralf, Hassel, Jessica C. , Haferkamp, Sebastian, Kähler, Katharina C., Knorr, Harald, Kreuzberg, Nicole, Leiter, Ulrike , Loquai, Carmen, Meier, Friedegund , Meissner, Markus , Mohr, Peter , Pföhler, Claudia, Rahimi, Farnaz, Schadendorf, Dirk , Schell, Beatrice, Schlaak, Max , Terheyden, Patrick, Thoms, Kai-Martin, Schuler-Thurner, Beatrice, Ugurel, Selma , Ulrich, Jens, Utikal, Jochen , Weichenthal, Michael , Ziller, Fabian, Berking, Carola und Heppt, Markus V. (2022) Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity. Cancers 14 (3), S. 518. Volltext nicht vorhanden.

Mohr, Peter, Scherrer, Emilie, Assaf, Chalid, Bender, Marc , Berking, Carola, Chandwani, Sheenu, Eigentler, Thomas , Grimmelmann, Imke, Gutzmer, Ralf , Haferkamp, Sebastian, Hassel, Jessica , Hauschild, Axel , Herbst, Rudolf , Jiang, Ruixuan , Kähler, Katharina, Krepler, Clemens, Kreuter, Alexander , Leiter, Ulrike, Loquai, Carmen, Meier, Friedegund , Pföhler, Claudia, Rudolph, Anja, Schadendorf, Dirk, Schiavone, Maximo, Schley, Gaston, Terheyden, Patrick, Ugurel, Selma , Ulrich, Jens, Utikal, Jochen , Weishaupt, Carsten , Welzel, Julia und Weichenthal, Michael (2022) Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany. Cancers 14 (7), S. 1804. Volltext nicht vorhanden.

Haist, Maximilian , Stege, Henner, Lang, Berenice Mareen, Tsochataridou, Aikaterini, Salzmann, Martin, Mohr, Peter, Schadendorf, Dirk, Ugurel, Selma , Placke, Jan-Malte, Weichenthal, Michael , Gutzmer, Ralf , Leiter, Ulrike , Kaatz, Martin, Haferkamp, Sebastian, Berking, Carola, Heppt, Markus , Tschechne, Barbara, Schummer, Patrick, Gebhardt, Christoffer , Grabbe, Stephan und Loquai, Carmen (2022) Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry. Cancers 14 (22), S. 5543. Volltext nicht vorhanden.

2021

van Akkooi, Alexander C. J., Haferkamp, Sebastian, Papa, Sophie, Franke, Viola, Pinter, Andreas, Weishaupt, Carsten, Huber, Margit A., Loquai, Carmen, Richtig, Erika, Gokani, Priya, Öhrling, Katarina, Louie, Karly S. und Mohr, Peter (2021) A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB–IVM1a Melanoma in Four European Countries. Advances in Therapy 38 (2), S. 1245-1262. Volltext nicht vorhanden.

Zaremba, Anne, Philip, Manuel, Hassel, Jessica C., Glutsch, Valerie, Fiocco, Zeno, Loquai, Carmen, Rafei-Shamsabadi, David , Gutzmer, Ralf, Utikal, Jochen, Haferkamp, Sebastian , Reinhardt, Lydia, Kähler, Katharina C., Weishaupt, Carsten, Moreira, Alvaro, Thoms, Kai-Martin, Wilhelm, Tabea, Pföhler, Claudia, Roesch, Alexander, Ugurel, Selma, Zimmer, Lisa , Stadtler, Nadine, Sucker, Antje, Kiecker, Felix, Heinzerling, Lucie, Meier, Friedegund, Meiss, Frank, Schlaak, Max, Schilling, Bastian, Horn, Susanne, Schadendorf, Dirk und Livingstone, Elisabeth (2021) Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases. European Journal of Cancer 152, S. 139-154. Volltext nicht vorhanden.

Stege, Henner, Haist, Maximilian , Schultheis, Michael, Fleischer, Maria Isabel, Mohr, Peter, Meier, Friedegund, Schadendorf, Dirk, Ugurel, Selma, Livingstone, Elisabeth , Zimmer, Lisa , Herbst, Rudolf, Pföhler, Claudia, Kähler, Katharina, Weichenthal, Michael, Terheyden, Patrick, Nashan, Dorothée, Debus, Dirk, Kaatz, Martin, Ziller, Fabian, Haferkamp, Sebastian , Forschner, Andrea, Leiter, Ulrike, Kreuter, Alexander , Ulrich, Jens, Kleemann, Johannes, Bradfisch, Fabienne, Grabbe, Stephan und Loquai, Carmen (2021) Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma—A Retrospective Multicenter ADOReg Study. Cancers 13 (10), S. 2312. Volltext nicht vorhanden.

Koch, Elias, Petzold, Anne, Wessely, Anja , Dippel, Edgar, Gesierich, Anja, Gutzmer, Ralf, Hassel, Jessica, Haferkamp, Sebastian , Hohberger, Bettina, Kähler, Katharina, Knorr, Harald, Kreuzberg, Nicole, Leiter, Ulrike, Loquai, Carmen, Meier, Friedegund, Meissner, Markus, Mohr, Peter, Pföhler, Claudia, Rahimi, Farnaz, Schadendorf, Dirk, Schell, Beatrice, Schlaak, Max, Terheyden, Patrick, Thoms, Kai-Martin, Schuler-Thurner, Beatrice, Ugurel, Selma, Ulrich, Jens, Utikal, Jochen, Weichenthal, Michael, Ziller, Fabian, Berking, Carola und Heppt, Markus (2021) Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis. Cancers 13 (13), S. 3359. Volltext nicht vorhanden.

Knispel, Sarah, Gassenmaier, Maximilian, Menzies, Alexander M., Loquai, Carmen, Johnson, Douglas B., Franklin, Cindy , Gutzmer, Ralf, Hassel, Jessica C., Weishaupt, Carsten, Eigentler, Thomas, Schilling, Bastian, Schummer, Patrick , Sirokay, Judith , Kiecker, Felix, Owen, Carina N., Fleischer, Maria I., Cann, Christopher, Kähler, Katharina C., Mohr, Peter, Bluhm, Leonie, Niebel, Dennis , Thoms, Kai-Martin, Goldinger, Simone M., Reinhardt, Lydia, Meier, Friedegund, Berking, Carola, Reinhard, Raphael, Susok, Laura, Ascierto, Paolo A., Drexler, Konstantin, Pföhler, Claudia, Tietze, Julia, Heinzerling, Lucie, Livingstone, Elisabeth, Ugurel, Selma, Long, Georgina V. , Stang, Andreas, Schadendorf, Dirk und Zimmer, Lisa (2021) Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition. European Journal of Cancer 148, S. 61-75. Volltext nicht vorhanden.

Steeb, Theresa, Wessely, Anja, Alter, Mareike, Bayerl, Christiane, Bender, Armin, Bruning, Guido, Dabrowski, Evelyn, Debus, Dirk, Devereux, Nina, Dippel, Edgar, Drexler, Konstantin, Dücker, Pia, Dummer, Reinhard, Emmert, Steffen, Elsner, Peter, Enk, Alexander, Gebhardt, Christoffer, Gesierich, Anja, Goebeler, Matthias, Goerdt, Sergij, Goetze, Steven, Gutzmer, Ralf, Haferkamp, Sebastian, Hansel, Gesina, Hassel, Jessica C., Heinzerling, Lucie, Kähler, Katharina C., Kaume, Kjell M., Krapf, Wolfgang, Kreuzberg, Nicole, Lehmann, Percy, Livingstone, Elisabeth, Löffler, Harald, Loquai, Carmen, Mauch, Cornelia, Mangana, Johanna, Meier, Friedegund, Meissner, Markus, Moritz, Rose K. C., Maul, Lara Valeska, Müller, Verena, Mohr, Peter, Navarini, Alexander, Van Nguyen, Ahn, Pfeiffer, Christiane, Pföhler, Claudia, Posch, Christian, Richtig, Erika, Rompel, Rainer, Sachse, Michael M., Sauder, Stefanie, Schadendorf, Dirk, Schatton, Kerstin, Schulze, Hans-Joachim, Schultz, Erwin, Schilling, Bastian, Schmuth, Matthias, Simon, Jan. C., Streit, Markus, Terheyden, Patrick, Thiem, Alexander, Tüting, Thomas, Welzel, Julia, Weyandt, Gerhard, Wesselmann, Ulrich, Wollina, Uwe, Ziemer, Mirjana, Zimmer, Lisa, Zutt, Markus, Berking, Carola, Schlaak, Max und Heppt, Markus V. (2021) Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG). Journal of Cancer Research and Clinical Oncology 147 (6), S. 1763-1771. Volltext nicht vorhanden.

Vogt, Jeannette , Beyer, Franziska, Sistermanns, Jochen, Kuon, Jonas, Kahl, Christoph, Alt-Epping, Bernd, Stevens, Susanne, Ahlborn, Miriam, George, Christian, Heider, Andrea, Tienken, Maria, Loquai, Carmen, Stahlhut, Kerstin, Ruellan, Anne, Kubin, Thomas, Dietz, Andreas, Oechsle, Karin, Mehnert-Theuerkauf, Anja , Oorschot, Birgitt, Thomas, Michael, Ortmann, Olaf, Engel, Christoph und Lordick, Florian (2021) Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course. The Oncologist 26 (6), e1058-e1065.

2020

Zimmer, Lisa, Livingstone, Elisabeth, Hassel, Jessica C., Fluck, Michael, Eigentler, Thomas, Loquai, Carmen, Haferkamp, Sebastian, Gutzmer, Ralf, Meier, Friedegund, Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian, Kieker, Felix, Dippel, Edgar, Rösch, Alexander, Simon, Jan-Christoph, Conrad, Beate, Körner, Silvia, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C., Schadendorf, Dirk, Berking, Carola, Herbst, Rudolf A., Martens, Uwe M., Sell, Sabine, Stadler, Rudolf, Terheyden, Patrick und Utikal, Jochen (2020) Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet 395 (10236), S. 1558-1568. Volltext nicht vorhanden.

Amaral, Teresa, Kiecker, Felix, Schaefer, Sarah, Stege, Henner, Kaehler, Katharina, Terheyden, Patrick, Gesierich, Anja, Gutzmer, Ralf, Haferkamp, Sebastian, Uttikal, Jochen, Berking, Carola, Rafei-Shamsabadi, David, Reinhardt, Lydia, Meier, Friedegund, Karoglan, Ante, Posch, Christian, Gambichler, Thilo, Pfoehler, Claudia, Thoms, Kai, Tietze, Julia, Debus, Dirk, Herbst, Rudolf, Emmert, Steffen, Loquai, Carmen, Hassel, Jessica C, Meiss, Frank, Tueting, Thomas, Heinrich, Vanessa, Eigentler, Thomas, Garbe, Claus und Zimmer, Lisa (2020) Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients. Journal for ImmunoTherapy of Cancer 8 (1), e000333. Volltext nicht vorhanden.

Leiter, Ulrike, Loquai, Carmen, Reinhardt, Lydia, Rafei-Shamsabadi, David , Gutzmer, Ralf, Kaehler, Katharina, Heinzerling, Lucie, Hassel, Jessica C, Glutsch, Valerie, Sirokay, Judith, Schlecht, Nora, Rübben, Albert, Gambichler, Thilo, Schatton, Kerstin, Pfoehler, Claudia, Franklin, Cindy, Terheyden, Patrick, Haferkamp, Sebastian, Mohr, Peter, Bischof, Lena, Livingstone, Elisabeth, Zimmer, Lisa, Weichenthal, Michael, Schadendorf, Dirk, Meiwes, Andreas, Keim, Ulrike, Garbe, Claus, Becker, Jürgen Christian und Ugurel, Selma (2020) Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients. Journal for ImmunoTherapy of Cancer 8 (2), e000897. Volltext nicht vorhanden.

2019

Liu, David, Schilling, Bastian , Liu, Derek, Sucker, Antje, Livingstone, Elisabeth, Jerby-Arnon, Livnat, Zimmer, Lisa, Gutzmer, Ralf, Satzger, Imke, Loquai, Carmen, Grabbe, Stephan, Vokes, Natalie, Margolis, Claire A., Conway, Jake, He, Meng Xiao, Elmarakeby, Haitham , Dietlein, Felix, Miao, Diana, Tracy, Adam, Gogas, Helen, Goldinger, Simone M., Utikal, Jochen, Blank, Christian U., Rauschenberg, Ricarda, von Bubnoff, Dagmar, Krackhardt, Angela, Weide, Benjamin, Haferkamp, Sebastian, Kiecker, Felix, Izar, Ben, Garraway, Levi, Regev, Aviv, Flaherty, Keith, Paschen, Annette, Van Allen, Eliezer M. und Schadendorf, Dirk (2019) Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nature Medicine 25 (12), S. 1916-1927. Volltext nicht vorhanden.

2017

Heppt, Markus V., Heinzerling, Lucie, Kähler, Katharina C., Forschner, Andrea, Kirchberger, Michael C., Loquai, Carmen, Meissner, Markus, Meier, Friedegund, Terheyden, Patrick, Schell, Beatrice, Herbst, Rudolf, Göppner, Daniela, Kiecker, Felix, Rafei-Shamsabadi, David, Haferkamp, Sebastian, Huber, Margit A., Utikal, Jochen, Ziemer, Mirjana, Bumeder, Irmgard, Pfeiffer, Christiane, Schäd, Susanne G., Schmid-Tannwald, Christoph, Tietze, Julia K., Eigentler, Thomas K. und Berking, Carola (2017) Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition. European Journal of Cancer 82, S. 56-65. Volltext nicht vorhanden.

Diese Liste wurde erzeugt am Sat Apr 27 04:20:13 2024 CEST.
  1. Universität

Universitätsbibliothek

Publikationsserver

Kontakt:

Publizieren: oa@ur.de
0941 943 -4239 oder -69394

Dissertationen: dissertationen@ur.de
0941 943 -3904

Forschungsdaten: datahub@ur.de
0941 943 -5707

Ansprechpartner